• Clover Health held its Q2 2026 earnings call with CEO Andrew Toy, Interim CFO Clay Thornton, IR head Ryan Schmidt.
• Q2 results: Medicare Advantage membership up 48% to 157,000; total revenue USD 743 million; adjusted EBITDA USD 41 million; GAAP net income USD 28 million.
• Raised FY2026 outlook: revenue USD 2.92-3 billion; adjusted EBITDA USD 70-85 million; GAAP net income USD 20-35 million; MA membership 156,000-158,000.
• CMS recalculation moved all MA members into 4.5-Star plans for payment year 2027; management expects added bid flexibility, not a change in core earnings drivers.
• Management highlighted cohort maturation under Clover Assistant as the key 2027 driver; cited about USD 70 PMPM gross profit lift from Year 1 to Year 2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.